Loading, please wait ...


News Analytics

FDA Social Graphic.
This guidance conveys recommendations to holders of approved new drug applications (NDAs), biologics license applications (BLAs), and abbreviated new drug applications (ANDAs) regarding the reporting and implementation of some common changes to container closure system (CCS) components consisting of glass vials and stoppers for approved sterile drug products, including biological products, administered parenterally.

Subject Matter

  • Government and social 31.63%
    • Legal, courts and investigations 100.00%
  • Science and technology 26.53%
  • Healthcare 21.43%
    • Health, disease and medicine 100.00%
  • Business, economics, society 20.41%
    • Society and people 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions